PRODUCT DESCRIPTION:

Stanozolol is a synthetic anabolic steroid derived from dihydrotestosterone (DHT), with strong anabolic and moderate androgenic properties.

It is used under medical supervision to manage hereditary angioedema, catabolic states, and certain bone marrow disorders, as well as in investigational settings for protein-sparing and recovery enhancement.

Offered in a 50 MG/ML aqueous suspension, Stanozolol Injection provides high anabolic activity with minimal water retention, making it suitable for short-term therapeutic or clinical research use.

Manufactured in GMP-compliant facilities, it ensures precision dosing and product stability.

Formulation & Presentation:

• Dosage Form: Injectable Aqueous Solution/Suspension
• Presentation: Sterile, single-use ampoule or vial (customizable as per market demand)
• Available Strengths: 50 MG/ML Vial/Ampoule
• Route of Administration: Intramuscular (IM), or as per clinical indication and severity (As per physician’s discretion or decision)

Therapeutic Indications:

• Adjunct therapy in hereditary angioedema to reduce severity and frequency of attacks
• Supportive treatment in catabolic states, severe trauma, or chronic illness-associated muscle wasting
• Off-label investigational use in anemia, burn recovery, or protein-energy malnutrition
• Not approved for routine therapeutic use in many countries; regulatory oversight required

Side Effects:

• COMMON:
  • Injection site pain or irritation
  • Acne and oily skin
  • Headache or insomnia
  • Changes in libido
• SERIOUS (RARE):
  • Hepatotoxicity (with prolonged use)
  • Virilization in female patients
  • Altered lipid profiles or cardiovascular strain
  • Suppression of endogenous testosterone
• PRECAUTIONS:
  • Contraindicated in patients with prostate or breast carcinoma, or severe hepatic dysfunction
  • Regular monitoring of liver enzymes, lipid profile, and hematologic parameters is essential
  • Should be administered under strict medical supervision in compliance with applicable regulations
  • Misuse outside therapeutic indication poses significant health risks and is legally restricted in many countries